-
Big Drug Cos. Are Slackers in Emerging Mkts.
Wednesday, March 17, 2010 - 2:43pm
The leading drug makers aren’t doing enough to gain market share in emerging markets, according to a report that was issued by IMS Health, a research company based in Norwalk, Conn., that tracks prescriptions and other data on drug sales. That’s according to an article in today’s New York Times....
Read More >> -
Merck leads drug stocks up
Wednesday, January 13, 2010 - 3:01pm
Shares of pharmaceutical giant Merck & Co. (NYSE: MRK) were up after analysts at Credit Suisse upgraded the stock rating from a neutral to an outperform and raised the target price from $35 to $47. Credit Suisse cited the many promising products in Merck's pipeline. Merck Chief Executive...
Read More >>
Drug companies
From Benzinga's Newsdesk
- 6:20 AM Brean Murray Carret Initiates Coverage on Seachange International at Buy, Announces PT of $11
- 6:18 AM Sterne Agee Maintains Southwest Airlines at Neutral, Lowers PT from $16 to $13
- 6:18 AM Jefferies & Company Maintains Monsanto at Hold, Raises PT from $81 to $86
- 6:18 AM Deutsche Bank Maintains Acme Packet at Hold, Lowers PT from $25 to $23
- 6:15 AM DA Davidson Maintains Texas Capital Bancshares at Buy, Raises PT from $41.5 to $45
- 6:15 AM Deutsche Bank Maintains Laboratory of America Holdings at Buy, Lowers PT from $100 to $98
- 6:15 AM Imperial Capital Maintains Spirit Airlines at Outperform, Raises PT from $37 to $41
- 06:09 AM Japan Housing Starts Rise 10.3% In April
- 6:07 AM Imperial Capital Maintains Allegiant Travel at Outperform, Raises PT from $80 to $98
- 06:06 AM Bank Hapoalim's Isracard Q1 Net Profit Rises 23%
- 6:06 AM Imperial Capital Initiates Coverage on Orbital Sciences at Outperform, Announces PT of $19
- 6:02 AM Morgan Stanley Upgrades Altera from Equal-weight to Overweight, Announces PT of $40
- 6:01 AM Canaccord Upgrades Coinstar from Hold to Buy, Raises PT from $70 to $71
- 6:00 AM JP Morgan Upgrades Omnivision Technologies from Neutral to Overweight, Maintains PT at $21
- 5:59 AM JP Morgan Upgrades Synchronoss Technologies from Neutral to Overweight, Maintains PT at $27
Brain Trust
- Japan Housing Starts Rise 10.3% In April
- Bank Hapoalim's Isracard Q1 Net Profit Rises 23%
- Fitbug Posts Narrower Full-Year Loss
- Bank Leumi Posts Decline In Q1 Net Profit
- Strabag Posts Wider Q1 Loss
- Brazil Lowers Key Rate To 8.5%
- Japan's Industrial Production Rise 0.2% In April
- DLF FQ4 Net Profit Drops 39%
- Prudential To Acquire SRLC America For $621M
- India's Q4 GDP Rate Drops To 5.3%
- Is Facebook Secretly Cloning the iPhone 5?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Was IBM Smart to Ban Siri?
- James Altucher Article Sends Neonode Soaring
- 5 Small-Cap Short Ideas
- Why Einhorn Is Wrong About Apple
- Facebook and Apple Together at Last?
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- Social Media Chatter on Dell Around Its Earnings Report
